Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease

Pharmacol Res. 2024 Nov:209:107473. doi: 10.1016/j.phrs.2024.107473. Epub 2024 Oct 18.
No abstract available

Keywords: Alzheimer's disease; Sodium-glucose cotransporter 2 inhibitors.

Publication types

  • Letter